Last reviewed · How we verify
NCT05443698: SELF-GYN1
SELF-GYN1 (Sonograms Enable Looking Forward- Get Your iNformation 1 Trial)
NA trial testing Transvaginal ultrasound in Fertility Risk in 365 participants. Completed in 14 July 2023.
14 July 2023
Quick facts
| Lead sponsor | Turtle Health, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 365 |
| Start date | 25 July 2022 |
| Primary completion | 14 July 2023 |
| Estimated completion | 14 July 2023 |
| Sites | 2 locations across United States |
Drugs / interventions tested
- Transvaginal ultrasound
Conditions studied
- Fertility Risk — all drugs for Fertility Risk →
Sponsor
Turtle Health, Inc.
Who can join
22 and older, female only, with Fertility Risk. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This clinical trial will evaluate the efficacy and safety of the use of the Turtle Health Ultrasound Scanner for the acquisition of transvaginal ultrasound images by a study participant, with no previous training, in her home when guided by real-time remote supervision from a qualified and specially trained ultrasound technologist.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05443698
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transvaginal ultrasound
Trials testing the same drug.
- NCT07114705 — The Relationship Between the Number of Ceserean Sections and Scar Niche Development · not yet recruiting
- NCT06968364 — FB-CT2 Includes Two Prospective, Multi-centre Studies With a Medical Device in Hospital Settings: a Randomized, Dual-arm · NA · recruiting
- NCT07264933 — Postplacental Copper Intrauterine Device Versus Postpartum Progesterone-only Pills on Uterine Niche Formation · NA · completed
- NCT06828536 — Female Genital Schistosomiasis in Migrant Women: A Pilot Study · NA · not yet recruiting
- NCT06041347 — Learning Curve for the Visualization of Sacral Plexus on TVS · unknown
Other Turtle Health, Inc. trials
Trials by the same sponsor.
- NCT05509322 — Care Expansion Across Remote Environments - Sub-Study of the SELF-GYN1 Trial · NA · withdrawn
- NCT05282524 — Helping Adults Perform Transvaginal Exams Via Coaching at Home · NA · completed
- NCT05004870 — Home Examinations Researching and Understanding Submucosal Evaluations · NA · withdrawn
- NCT04784325 — Anti-Mullerian Hormone - At My Home · NA · completed
- NCT04687189 — Sonograms Enable Looking Forward - Home Examinations Led by Providers Validation Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05443698 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Turtle Health, Inc.
- Last refreshed: 17 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05443698.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing